BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9408014)

  • 21. The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction.
    Peeters AC; van der Molen EF; Blom HJ; den Heijer M
    Thromb Haemost; 2004 Nov; 92(5):1086-91. PubMed ID: 15543337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma thrombomodulin in orthotopic liver transplantation.
    Boutiere B; Arnoux D; Boffa MC; Samson D; Le Treut YP; Sampol J
    Transplantation; 1994 Dec; 58(12):1352-5. PubMed ID: 7809928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
    Alizadeh Dehnavi R; Beishuizen ED; van de Ree MA; Le Cessie S; Huisman MV; Kluft C; Princen HM; Tamsma JT
    Eur J Intern Med; 2008 Mar; 19(2):115-21. PubMed ID: 18249307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
    Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.
    Van den Berg M; Boers GH; Franken DG; Blom HJ; Van Kamp GJ; Jakobs C; Rauwerda JA; Kluft C; Stehouwert CD
    Eur J Clin Invest; 1995 Mar; 25(3):176-81. PubMed ID: 7781664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
    Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
    Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
    Tam LS; Fan B; Li EK; Thomas GN; Yim SF; Haines CJ; Tomlinson B
    J Rheumatol; 2003 Jul; 30(7):1479-84. PubMed ID: 12858444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2005 Feb; 15(1):26-30. PubMed ID: 15831157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
    Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
    Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
    Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic cigarette smoking on endothelial function in young men.
    Ozaki K; Hori T; Ishibashi T; Nishio M; Aizawa Y
    J Cardiol; 2010 Nov; 56(3):307-13. PubMed ID: 20943346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients.
    Kario K; Matsuo T; Kobayashi H; Kanai N; Hoshide S; Mitsuhashi T; Ikeda U; Nishiuma S; Matsuo M; Shimada K
    J Am Coll Cardiol; 1998 Aug; 32(2):444-50. PubMed ID: 9708474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
    Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes is associated with a high incidence of endothelial-binding antibodies which do not correlate with retinopathy, von Willebrand factor, angiotensin-converting enzyme or C-reactive protein.
    Petty RG; Pottinger BE; Greenwood RM; Pearson JD; Mahler RF
    Diabetes Res; 1991 Jul; 17(3):115-23. PubMed ID: 1668655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus].
    Galajda P; Martinka E; Baláz D; Stasko J; Kerný J; Planková E; Mokán M; Kubisz P
    Vnitr Lek; 1997 Nov; 43(11):744-7. PubMed ID: 9650506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
    Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
    Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.